Radiolabeled choline as a proliferation marker: Comparison with radiolabeled acetate
- 1 October 2004
- journal article
- research article
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 31 (7), 859-865
- https://doi.org/10.1016/j.nucmedbio.2004.05.002
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Experience with carbon-11 choline positron emission tomography in prostate carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- Increased Choline Kinase Activity and Elevated Phosphocholine Levels in Human Colon Cancer†Japanese Journal of Cancer Research, 1999
- Brain tumors: detection with C-11 choline PET.Radiology, 1997
- Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Requirement of phosphatidylcholine for normal progression through the cell cycle in C3H/10T1/2 fibroblasts.Journal of Lipid Research, 1994
- The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rateBritish Journal of Cancer, 1991
- Florodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumorsCancer, 1988
- Lipid requirement for cell cyclingExperimental Cell Research, 1977
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959